Vir Biotechnology (VIR) EPS (Basic) (2018 - 2026)
Vir Biotechnology (VIR) reported EPS (Basic) of -$0.85 for Q1 2026, up 3.06% on a YoY basis from -$0.83 in Q1 2025, and down 175.28% sequentially from -$0.31 in Q4 2025.
Vir Biotechnology (VIR) EPS (Basic) (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of EPS (Basic) data on file, last reported at -$0.85 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 3.06% year-over-year to -$0.85; the trailing twelve-month figure through Mar 2026 stood at -$3.0 (up 28.5% YoY), and the FY2025 full-year result was -$3.16, up 17.47% from the prior year.
- EPS (Basic) retreated to -$0.85 in Q1 2026, from -$0.31 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $3.93 in Q1 2022 to a low of -$1.56 in Q3 2024.
- A 5-year average of -$0.5 and a median of -$0.85 in 2026 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 396.96% in 2022, while the deepest fall reached 221.57% in 2022.
- Tracing VIR's EPS (Basic) over 5 years: stood at -$0.77 in 2022, then retreated by 12.85% to -$0.86 in 2023, then gained by 11.22% to -$0.77 in 2024, then jumped by 59.63% to -$0.31 in 2025, then slumped by 175.28% to -$0.85 in 2026.
- Business Quant data shows VIR's EPS (Basic) at -$0.85 in Q1 2026, -$0.31 in Q4 2025, and -$1.17 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | -0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.85 |
| Dec 31, 2025 | -0.31 |
| Sep 30, 2025 | -1.17 |
| Jun 30, 2025 | -0.80 |
| Mar 31, 2025 | -0.88 |
| Dec 31, 2024 | -0.77 |
| Sep 30, 2024 | -1.56 |
| Jun 30, 2024 | -1.02 |
| Mar 31, 2024 | -0.48 |
| Dec 31, 2023 | -0.86 |
| Sep 30, 2023 | -1.22 |
| Jun 30, 2023 | -1.45 |
| Mar 31, 2023 | -1.06 |
| Dec 31, 2022 | -0.77 |
| Sep 30, 2022 | 1.32 |
| Jun 30, 2022 | -0.58 |
| Mar 31, 2022 | 3.93 |
| Dec 31, 2021 | 4.04 |
| Sep 30, 2021 | 0.85 |
| Jun 30, 2021 | 0.48 |